4//SEC Filing
Chang Xiaowei 4
Accession 0000899243-23-015170
CIK 0001836056other
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 4:11 PM ET
Size
7.9 KB
Accession
0000899243-23-015170
Insider Transaction Report
Form 4
Chang Xiaowei
Director
Transactions
- Award
Cash-Settled RSU's
2023-06-07−85,000→ 85,000 total→ Ordinary Shares (85,000 underlying) - Award
Cash-Settled RSU's
2023-06-07−125,000→ 125,000 total→ Ordinary Shares (125,000 underlying)
Footnotes (3)
- [F1]Represents grant of Restricted Stock Units (the "RSUs") payable solely in cash based on the market price of the underlying Ordinary Shares on the vesting date (the reporting person will never receive the Ordinary Shares).
- [F2]The RSUs vest on the earlier of (i) the one year anniversary of the date of grant and (ii) the day before the next annual general meeting.
- [F3]The RSUs vest in three (3) successive equal annual installments following June 8, 2023.
Documents
Issuer
Ambrx Biopharma Inc.
CIK 0001836056
Entity typeother
Related Parties
1- filerCIK 0001866837
Filing Metadata
- Form type
- 4
- Filed
- Jun 8, 8:00 PM ET
- Accepted
- Jun 9, 4:11 PM ET
- Size
- 7.9 KB